Survival and differentiation of porcine hepatocytes encapsulated by semiautomatic device and allotransplanted in large number without immunosuppression

Journal of Hepatology

Volumn 35, Issue 2, 2001, Pages 208-216

  Benoist, Stéphane ^a   Sarkis, Riad ^a   Barbu, Véronique ^a   Honiger, Jiri ^a   Lakehal, Fatima ^a   Becquemont, Laurent ^a   Baudrimont, Marielle ^a   Capeau, Jacqueline ^a   Housset, Chantal ^a   Nordlinger, Bernard ^a  

^a HÔPITAL SAINT ANTOINE   (France)

Author keywords

Allogeneic transplantation; Bioartificial liver; Function; Porcine hepatocyte; Survival

Indexed keywords

ALBUMIN; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; POLYMER;

ALLOGRAFT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FUNCTION; CELL STRUCTURE; CELL SURVIVAL; CONTROLLED STUDY; DEVICE; ELECTRON MICROSCOPY; ENCAPSULATION; ENZYME ACTIVITY; GENE EXPRESSION; HYDROXYLATION; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL; NONHUMAN; PERITONEAL CAVITY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ALBUMINS; ANIMALS; ARYL HYDROCARBON HYDROXYLASES; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSPLANTATION; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; DIFFUSION CHAMBERS, CULTURE; EQUIPMENT DESIGN; GENE EXPRESSION; HEPATOCYTES; IMMUNOSUPPRESSION; MICROSCOPY, ELECTRON; OXIDOREDUCTASES, N-DEMETHYLATING; SWINE; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 17944362808     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(01)00085-X     Document Type: Article

References (44)

1. Acute liver failure
2. Liver transplantation in patients with fulminant hepatic failure
3. Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experience
4. Auxiliary liver transplantation: Regeneration of the native liver and outcome in 30 patients with fulminant hepatic failure
5. A bioartificial liver to treat severe acute liver failure
6. Reversal of fulminant hepatic failure using an extracorporeal liver assist device
7. Hepatocyte transplantation: Back to the future
8. Development of a bioartificial liver using isolated hepatocytes
9. Transplantation of allogeneic hepatocytes without immunosuppression: Long-term survival
10. Survival and function of hepatocytes on a novel three-dimensional synthetic biodegradable polymer scaffold with an intrinsic network of channels
11. Evidence for survival and metabolic activity of encapsulated xenogeneic hepatocytes transplanted without immunosuppression in Gunn rats
12. Cryopreserved microencapsulated hepatocytes transplantation studies in Gunn rats
13. Internal bioartificial liver with xenogeneic hepatocytes prevents death from acute liver failure: An experimental study
14. Survival, proliferation, and functions of porcine hepatocytes encapsulated in coated alginate beads: A step towards a reliable bioartificial liver
15. Formation of porcine hepatocyte steroids for use in a bioartificial liver
16. Isolation and culture of porcine hepatocytes for artificial liver support
17. The pig as a potential organ donor for man. A study of potentially transferable disease from donor pig to recipient man
18. Hepatocyte transplantation
19. Semiautomatic macroencapsulation of large numbers of porcine hepatocytes by coextrusion with a solution of AN69 polymer
20. A technique for porcine hepatocytes harvest and description of differentiated metabolic functions in static culture
21. Permeability and biocompatibility of a new hydrogel used for encapsulation of hepatocytes
22. Nucleotide sequence of porcine liver albumin
23. High and low annealing temperatures increase both specificity and yield in touchdown and stepdown PCR
24. Quantitative estimation on minor mRNA by cDNA-polymerase chain reaction
25. Albumin messenger RNA as a marker of circulating hepatocytes in hepatocellular carcinoma
26. Presence and activity of cytochrome P450 isoforms in minipig liver microsomes. Comparison with human liver samples
27. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture
28. Treatment of the Crigler-Najjar syndrome type I with hepatocyte transplantation
29. The use of cultured hepatocyte infusion via the portal vein for the treatment of ornithine transcarbamoylase deficiency by transplantation of enzymatically competent ABO/Rh-matched cells
30. Hepatocyte transplantation as a bridge to orthotopic liver transplantation in terminal liver failure
31. Hepatocyte transplantation in acute liver failure
32. Xenotransplantation of isolated encapsulated porcine hepatocytes in the treatment of highly fulminant hepatic failure model
33. Correction of bilirubin conjugation in the Gunn rat using hepatocytes immobilized in alginate gel beads an extracorporeal bioartificial liver
34. Macroencapsulation of dopamine-secreting cells by coextrusion with an organic polymer solution
35. Functional activity of isolated pig hepatocytes attached to different extracellular matrix substrates. Implication for application of pig hepatocytes in a bioartificial liver
36. Reduction of serum cholesterol in Watanabe rabbits by xenogeneic hepatocellular transplantation
37. Long-term maintenance of the adult pattern of liver specific expression for P450b, P450c, albumin and alpha-foetoprotein genes in intrasplenically transplanted hepatocytes
38. In vitro evaluation of metabolic functions of a bioartificial liver
39. Encapsulated xenogeneic hepatocytes remain functional after peritoneal implantation despite immunization of the host
40. Clinical use of bioartificial liver in the treatment of acetaminophen-induced fulminant hepatic failure
41. Xenotransplantation of fetal porcine hepatocytes in rats using a tissue engineering approach
42. Experimental xenotransplantation of fresh isolated and cryopreserved pig hepatocytes: A biochemical and morphological study
43. Beneficial effects of immunoisolated fetal and neonatal pig liver fragments on acute liver failure in a large animal
44. Transplantation of hepatocytes for prevention of intracranial hypertension in pigs with ischemic liver failure